SCHEMBL21477286

SCHEMBL21477286

Oc1cccc(OCc2ccc(-n3cccn3)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.55
SIRT2 Q8IXJ6 1/20 0.45
SIRT1 Q96EB6 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
PTGER2 P43116 1/20 0.43
NOTUM Q6P988 1/20 0.43
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOB P27338 4/20 0.40
F2 P00734 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21480868 0.85 NOTUM (0.42) APPSIRT2SIRT1SIRT3PTGER2
SCHEMBL22964302 0.82 PPARG (0.42) APPSIRT2SIRT1SIRT3PTGER2
SCHEMBL16540016 0.80 MAOB (0.52) APPNOTUMNPC1RAB9AMAOB
SCHEMBL12989014 0.79 LMNA (0.50) NOTUMKDM4ENPC1GAAMAPT
SCHEMBL28573560 0.77 NOTUM (0.42) SIRT2SIRT1SIRT3PTGER2NOTUM
SCHEMBL27510857 0.76 SLC2A4 (0.58) NOTUMKDM4EMAPTSMN1; SMN2DRD2
SCHEMBL27735405 0.76 APP (0.77) APPKDM4EGAAMAPTRAB9A
SCHEMBL22964303 0.75 APP (0.70) APPMAPTRAB9ASMN1; SMN2MAOB
SCHEMBL16018314 0.75 APP (0.65) APPSMN1; SMN2MAOBF2DRD2
SCHEMBL29368413 0.74 ERCC1 (0.51) NOTUMKDM4ENPC1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961231-B2 NTCP inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-03-30 US disclosed
US-20210040072-A1 NTCP Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-02-11 US disclosed
WO-2019196953-A1 NTCP INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040072-A1 NTCP Inhibitors HAVCR2, NPC1, HMGCR APP 589/4885SIRT2 2356/4885SIRT1 1120/4885
US-10961231-B2 NTCP inhibitors HAVCR2, NPC1, HMGCR APP 589/4885SIRT2 2356/4885SIRT1 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.